These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9298736)

  • 1. Activation of liver disease in healthy hepatitis B surface antigen carriers during interferon-alpha treatment.
    Rodríguez-Iñigo E; Bartolomé J; López-Alcorocho JM; Contonat T; Oliva H; Carreño V
    J Med Virol; 1997 Sep; 53(1):76-80. PubMed ID: 9298736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B.
    Fattovich G; Brollo L; Boscaro S; Pontisso P; Giustina G; Criscuolo D; Maladorno D; Alberti A; Realdi G; Ruol A
    J Hepatol; 1989 Nov; 9(3):331-7. PubMed ID: 2691568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.
    Raptopoulou M; Orphanou H; Vrettou H; Akribiadis E; Chadzikonstantinou L; Goulis G
    Gut; 1993; 34(2 Suppl):S102-3. PubMed ID: 8314469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
    N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results.
    Bayraktar Y; Uzunalimoglu B; Arslan S; Koseoglu T; Kayhan B; Telatar H
    Gut; 1993; 34(2 Suppl):S101. PubMed ID: 8314468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon treatment in patients with chronic hepatitis C with normal alanine-aminotransferase activity.
    Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
    Hepatogastroenterology; 1999; 46(26):1094-9. PubMed ID: 10370673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
    Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
    Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems in the management of chronic hepatitis B with interferon: experience in a randomized, multicentre study.
    Realdi G; Fattovich G; Pastore G; Caredda F; Noventa F; Santantonio T; Moroni M; Criscuolo D; Maladorno D; Rugge M
    J Hepatol; 1990; 11 Suppl 1():S129-32. PubMed ID: 2079570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for chronic hepatitis B with lymphoblastoid interferon-alpha and levamisole.
    Fattovich G; Giustina G; Brollo L; Guido M; Pontisso P; Noventa F; Alberti A
    Hepatology; 1992 Nov; 16(5):1115-9. PubMed ID: 1427652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of patients with chronic hepatitis B after interferon treatment.
    Teuber G; Dienes HP; Meyer Zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1996 Apr; 34(4):230-6. PubMed ID: 8686350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
    Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
    Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
    Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
    Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
    Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.